×
Enjoying ad-free content?
Since July 1, 2024, we have disabled all ads to improve your reading experience.
This commitment costs us $10,000 a month. Your support can help us fill the gap.
Support us
Our journalism is banned in Russia. We need your help to keep providing you with the truth.

Russia to Start Mass Deliveries of Coronavirus Vaccine Next Month

A vaccination campaign will begin among Russian volunteers in October. Moskva News Agency

Russia plans to begin the first mass deliveries of its coronavirus vaccine in September, Health Minister Mikhail Murashko said Monday.

Russia has registered the Sputnik V adenoviral vector-based vaccine and is touting it as the world’s first despite it not having undergone large-scale trials to prove its safety and effectiveness. Russia is one of several countries racing to develop a proven vaccine against the disease that has infected 25.4 million and killed more than 850,000 people worldwide.

“First deliveries in large quantities will begin in September,” Murashko was quoted as saying by the state-run TASS news agency.

The health minister said production was underway in parallel with post-registration monitoring of the vaccine’s effectiveness. 

A mass vaccination campaign will begin among Russian volunteers in October, a month after industrial production is expected to launch, according to the head of the national sovereign fund paying for the vaccination project.

“The vaccine will be first and foremost shipped to health workers and teachers,” Murashko said, adding that the vaccination will be “completely voluntary.”

Some 2,500 out of 40,000 volunteers have been recruited for Phase 3 trials of the vaccine so far, he said.

“Several more vaccines are going through registration. We’ll reach maximum capacities in November-December,” Murashko said.

Russia says more than 20 countries have requested over 1 billion doses of the Sputnik V vaccine despite safety concerns.

Western scientists have raised concerns over the speed of development of Russian vaccines, suggesting that researchers might be cutting corners after coming under pressure from the authorities to deliver. Russia has dismissed the criticism as an attempt to undermine its research.

Sputnik V is expected to enter civilian circulation on Jan. 1, 2021, according to a registration certificate on the Russian Health Ministry’s website.

A Message from The Moscow Times:

Dear readers,

We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."

These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.

We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.

By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.

Once
Monthly
Annual
Continue
paiment methods
Not ready to support today?
Remind me later.

Read more